Atossa Therapeutics
ATOS
#10613
Rank
$20.64 M
Marketcap
$2.07
Share price
-5.48%
Change (1 day)
152.44%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2026 (TTM): -$37.65 Million USD

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -$34.77 Million USD a decrease over its 2024 earnings that were of -$25.51 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -$37.65 Million8.26%
2025 -$34.77 Million36.33%
2024 -$25.51 Million-15.25%
2023 -$30.1 Million11.62%
2022 -$26.96 Million30.84%
2021 -$20.61 Million15.58%
2020 -$17.83 Million3.41%
2019 -$17.24 Million51.16%
2018 -$11.41 Million40.41%
2017 -$8.13 Million27.54%
2016 -$6.37 Million-47.49%
2015 -$12.13 Million-17.25%
2014 -$14.66 Million35.91%
2013 -$10.79 Million112.3%
2012 -$5.08 Million46.53%
2011 -$3.47 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
$25.97 B-69,117.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
$1.37 B-3,755.59%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
$1.37 B-3,753.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
$41.68 M-210.73%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-$99.46 Million 164.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-$7.85 Million-79.17%๐Ÿ‡บ๐Ÿ‡ธ USA